Business
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announce...
About this update from Quarterback Resources Inc.
[{"type":"text","content":"Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $88,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). Eighty thousand dollars of this payment is the third installment of a $700,000 purchase order the Company received from HDMT earlier this year and the additional $8,000 is a new order for LuViva components. The four LuViva devices and components will be shipped this month and will bring the total number of devices shipped to seven of the 35 devices due over the next several months. HDMT is in Hangzhou City, Zhejiang Province, where it is the exclusive gynecology products provider for 42 hospitals that perform approximately two million cervical cancer screenings annually.\n \n\n The purchase order with HDMT was recently complemented by a new agreement with Yuanshuo Medical Instruments Corporation (YMIC) for an initial $200,000 purchase of LuViva devices and parts. YMIC is headquartered in Jiangsu province where it will distribute LuViva products.\n \n\n\n About Guided Therapeutics\n \n\n\n Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company’s first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit:\n \n www.guidedinc.com\n \n .\n \n\n\n The Guided Therapeutics LuViva\n \n ®\n \n Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and \"Early detection, better outcomes\" are registered trademarks owned by Guided Therapeutics, Inc.\n \n\n\n Forward-Looking Statements Disclaimer: A number of the matters and subject areas ...